Valuation: Compumedics Limited

Market Cap 45.95M 32.03M 28.17M 26.17M 24.07M 45.14M 3.1B 313M 122M 1.51B 120M 118M 5.25B P/E 2026 *
15.3x
P/E 2027 * 6.22x
Enterprise Value 45.95M 32.03M 28.17M 26.17M 24.07M 45.14M 3.1B 313M 122M 1.51B 120M 118M 5.25B EV / Sales 2026 *
0.69x
EV / Sales 2027 * 0.58x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.7%
1 day-6.12%
1 week+2.22%
Current month-9.80%
1 month-8.00%
3 months-22.03%
6 months-48.89%
Current year-31.34%
1 week 0.22
Extreme 0.215
0.24
1 month 0.22
Extreme 0.215
0.3
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 2010-12-15
Director of Finance/CFO 61 2009-11-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 2010-12-15
Director/Board Member 61 1999-12-31
Director/Board Member - 2022-10-26
Change 5-day change 1-year change 3-year change Capi.($)
-6.12%+2.22%-22.03%+35.29% 32.03M
+8.71%+5.36%+22.63%+1.80% 213B
+7.46%-6.10%-2.72%-24.77% 135B
-2.54%-17.48%-33.85%-1.38% 117B
+1.42%-2.33%-59.56%-18.02% 64.78B
-0.65%-4.58%+8.98%-9.45% 48.26B
+1.40%-1.82%-28.02%-32.71% 43.08B
+4.71%+2.67%+16.97%+9.50% 39.47B
+3.13%+1.12%+29.35%+32.45% 37.55B
+3.14%+3.47%+88.18%+3.34% 29.78B
Average +2.39%-2.81%+1.99%-0.39% 72.83B
Weighted average by Cap. +4.75%-4.90%+0.33%-6.14%

Financials

2026 *2027 *
Net sales 66.3M 46.22M 40.65M 37.76M 34.73M 65.13M 4.48B 452M 176M 2.18B 174M 170M 7.57B 79.7M 55.56M 48.86M 45.39M 41.75M 78.3M 5.38B 543M 212M 2.62B 209M 204M 9.1B
Net income 3.8M 2.65M 2.33M 2.16M 1.99M 3.73M 257M 25.88M 10.1M 125M 9.94M 9.73M 434M 9M 6.27M 5.52M 5.13M 4.71M 8.84M 608M 61.3M 23.91M 296M 23.55M 23.04M 1.03B
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
26-07-22 A$0.2300 -6.12% 2,400
26-07-21 A$0.2450 +13.95% 9,802
26-07-20 A$0.2150 -2.27% 38,618
26-07-17 A$0.2200 -2.22% 6,250
26-07-16 A$0.2250 0.00% 85,374
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2300AUD
Average target price
0.8000AUD
Spread / Average Target
+247.83%

Annual profits - Rate of surprise